Cargando…

High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer

BACKGROUND: Taxol resistance in serous ovarian cancer is responsible for its poor prognosis, yet the underlying mechanism is still poorly understood. Thus, we probed the mechanism of Taxol resistance in serous ovarian cancer with multiple bioinformatic methods to provide novel insights into potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yuqing, Lin, Hui, Chen, Kelie, Ge, Wanzhong, Xia, Dajing, Wu, Yihua, Lu, Weiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044796/ https://www.ncbi.nlm.nih.gov/pubmed/35477477 http://dx.doi.org/10.1186/s13048-022-00986-2

Ejemplares similares

Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
por: Zhang, Jing, et al.
Publicado: (2021)

Identification of a Novel Prognostic Classification Model in Epithelial Ovarian Cancer by Cluster Analysis
por: Chen, Kelie, et al.
Publicado: (2020)

Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
por: Hou, Shunyu, et al.
Publicado: (2018)

Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis
por: Wang, Fang, et al.
Publicado: (2023)

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
por: Xu, Junfen, et al.
Publicado: (2022)

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
por: Zheng, Fang, et al.
Publicado: (2023)

Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies
por: Zheng, Fang, et al.
Publicado: (2023)

The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
por: Shen, Yuanming, et al.
Publicado: (2022)

MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage
por: Chen, Kelie, et al.
Publicado: (2023)

LncRNA CASC15, MiR-23b Cluster and SMAD3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer
por: Lin, Hui, et al.
Publicado: (2022)

Impact of antitumor regimens on the outcomes of cancer patients with COVID-19: a pooled analysis
por: LU, Haohua, et al.
Publicado: (2021)

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1995)

Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
por: Shen, Xiameng, et al.
Publicado: (2021)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets
por: De, Alok, et al.
Publicado: (2020)

Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
por: Zhao, Xiaofeng, et al.
Publicado: (2017)

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
por: Wang, Xueqing, et al.
Publicado: (2013)

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells
por: Kim, Yong-Wan, et al.
Publicado: (2014)

Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
por: Zhou, Ming, et al.
Publicado: (2010)

Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer
por: Cen, Yixuan, et al.
Publicado: (2022)

Taxol: an important new drug in the management of epithelial ovarian cancer.
por: Markman, M.
Publicado: (1991)

MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples
por: Li, Xiao, et al.
Publicado: (2013)

Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
por: FENG, LIN, et al.
Publicado: (2015)

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.
por: Gore, M. E., et al.
Publicado: (1995)

Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts
por: LI, WEI, et al.
Publicado: (2013)

Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer
por: Brouwer-Visser, Jurriaan, et al.
Publicado: (2014)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose
por: Gao, Sheng, et al.
Publicado: (2021)

Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor
por: Sun, Nian-Kang, et al.
Publicado: (2015)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Autophagy and Tumor Database: ATdb, a novel database connecting autophagy and tumor
por: Chen, Kelie, et al.
Publicado: (2020)

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
por: Jekunen, A. P., et al.
Publicado: (1994)

Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
por: Sun, Nian-Kang, et al.
Publicado: (2014)

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma
por: Li, Wei, et al.
Publicado: (2012)

Prediction of chemotherapeutic resistance in serous ovarian cancer with low-density custom microarray
por: Zhu, Hong-Lan, et al.
Publicado: (2020)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin
por: LIU, LIANCHENG, et al.
Publicado: (2016)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_drk2ur9368qruqq5jckkt057op